Suppr超能文献

携带 CMY-2 β-内酰胺酶的 IncIγ 质粒的出现与携带国际流行 OXA-30 型 β-内酰胺酶的鼠伤寒沙门氏菌 ST19 型多药耐药克隆有关。

Emergence of an IncIγ plasmid encoding CMY-2 ß-lactamase associated with the international ST19 OXA-30-producing ß-lactamase Salmonella Typhimurium multidrug-resistant clone.

机构信息

Faculdade de Ciências da Nutrição e Alimentação, Universidade do Porto, Porto, Portugal.

出版信息

J Antimicrob Chemother. 2010 Oct;65(10):2097-100. doi: 10.1093/jac/dkq293. Epub 2010 Aug 4.

Abstract

OBJECTIVES

To analyse the genetic environment of the bla(CMY-2) gene in a multidrug-resistant isolate belonging to the OXA-30-producing Salmonella enterica serotype Typhimurium clone widespread in European countries.

METHODS

Preliminary characterization of CMY-2 was performed after determining the phenotype against β-lactams, the pI (isoelectric focusing) and the presence of bla genes (PCR). The genetic context of the bla(CMY-2) gene was identified by PCR mapping and further sequencing. Plasmid analysis included determination of transferability, size and content (S1-PFGE/hybridization), and characterization of the incompatibility group (PCR-based replicon typing, hybridization and sequencing).

RESULTS

The ΔISEcp1-bla(CMY-2)-blc-sugE cassette identified is located in the pndC-trbA region of an IncIγ conjugative plasmid designated pSTHV23035. This plasmid differs from previously described European IncI plasmids coding for CMY in the IncI replicon type and in the integration site of the element carrying bla(CMY-2).

CONCLUSIONS

The emergence of bla(CMY-2) located in a new IncIγ plasmid in an isolate belonging to the international widespread multidrug-resistant sequence type (ST) 19 OXA-30-producing Salmonella Typhimurium clone is reported for the first time. Acquisition of a new bla(CMY-2)-IncIγ plasmid by Salmonella multidrug-resistant strains is of concern since these plasmids diminish the activity of therapeutically important broad-spectrum β-lactams and contribute to the persistence and pathogenicity of widespread clones.

摘要

目的

分析广泛存在于欧洲国家的产 OXA-30 鼠伤寒沙门氏菌 OXA-30 型克隆中的多重耐药分离株 bla(CMY-2)基因的遗传环境。

方法

在确定对β-内酰胺的表型、pI(等电聚焦)和 bla 基因(PCR)存在后,对 CMY-2 进行初步特征分析。通过 PCR 图谱和进一步测序确定 bla(CMY-2)基因的遗传环境。质粒分析包括可转移性、大小和含量的确定(S1-PFGE/杂交),以及不相容群的特征(基于 PCR 的复制子分型、杂交和测序)。

结果

鉴定出的 ΔISEcp1-bla(CMY-2)-blc-sugE 盒位于被指定为 pSTHV23035 的 IncIγ 可接合质粒的 pndC-trbA 区。该质粒与先前描述的编码 CMY 的欧洲 IncI 质粒在 IncI 复制子类型和携带 bla(CMY-2)的元件的整合位点上有所不同。

结论

首次报道了在属于广泛流行的多药耐药序列型(ST)19 产 OXA-30 鼠伤寒沙门氏菌克隆的分离株中,bla(CMY-2)位于新的 IncIγ 质粒中的情况。由于这些质粒降低了治疗上重要的广谱β-内酰胺的活性,并有助于广泛流行克隆的持续存在和致病性,因此多药耐药的沙门氏菌菌株获得新的 bla(CMY-2)-IncIγ 质粒令人担忧。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验